Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$276.99M$276.99Mderived−3.1% vs Q4 2023 Net Income$49.46M$49.46MderivedN/M vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$151,817,000−1.3% Operating Incomederived$82,153,000N/M Operating Cash Flowderived$66,907,000+13.4% Free Cash Flowderived$63,764,000+13.0% Margins · derivedGross margin54.8%+1.0 pt vs Q4 2023
Operating margin29.7%+128.0 pt vs Q4 2023
Net margin17.9%+102.0 pt vs Q4 2023
ended Mar 31, 2024 · filed May 15, 2024 · 45 d after period end